Harald Lahner Selected Research

Hormones (Hormone)

1/2021

Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harald Lahner Research Topics

Disease

8	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2021 - 12/2011
6	Neoplasms (Cancer) 04/2021 - 03/2007
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
3	Obesity 01/2010 - 11/2007
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2021 - 01/2021
2	Acromegaly 01/2019 - 08/2010
1	Sepsis (Septicemia) 01/2022
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2021
1	Hypothyroidism 12/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Neuroendocrine Carcinoma 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Disease Progression 10/2017
1	Vitamin D Deficiency 06/2017
1	Fatigue 03/2016
1	Infections 03/2016
1	Stomatitis 03/2016
1	Primitive Neuroectodermal Tumors (PNET) 02/2016
1	Graves Disease (Basedow Disease) 04/2011
1	Hematoma 04/2011
1	Hypocalcemia 04/2011
1	Thyroid Diseases (Thyroid Disease) 04/2011
1	Vocal Cord Paralysis 04/2011
1	Hypertension (High Blood Pressure) 08/2010
1	Diabetes Mellitus 08/2010
1	Cushing Syndrome 06/2010
1	Adenoma (Adenomas) 06/2010
1	Pituitary Diseases (Disease, Anterior Pituitary) 03/2010
1	Insulin Resistance 11/2007
1	Menstruation Disturbances 11/2007
1	Body Weight (Weight, Body) 11/2007
1	Anovulation 11/2007
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2007
1	Acne Vulgaris 11/2007
1	Hyperandrogenism 11/2007
1	Overweight 11/2007
1	Hirsutism 03/2007
1	Leydig Cell Tumor 03/2007
1	Virilism (Virilization) 03/2007

Drug/Important Bio-Agent (IBA)

5	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 12/2011
4	Everolimus FDA Link 01/2018 - 02/2016
3	Ga(III)-DOTATOCIBA 04/2021 - 12/2011
3	Insulin (Novolin)FDA Link 01/2010 - 11/2007
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2021 - 12/2011
2	Edotreotide (SMT 487)IBA 04/2020 - 04/2020
2	Pharmaceutical PreparationsIBA 10/2017 - 03/2016
2	Testosterone (Sustanon)FDA Link 11/2007 - 03/2007
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Sunitinib (Sutent)FDA Link 12/2021
1	lanreotide (Somatuline)FDA Link 07/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2020
1	IpilimumabIBA 01/2020
1	NivolumabIBA 01/2020
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2019
1	Vitamin D FDA LinkGeneric 06/2017
1	TOR Serine-Threonine KinasesIBA 02/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2016
1	dactolisibIBA 02/2016
1	LigandsIBA 01/2013
1	gallium Ga 68 dotatateIBA 12/2011
1	HDL LipoproteinsIBA 08/2010
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2010
1	CholesterolIBA 08/2010
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2010
1	LDL Lipoproteins (beta Lipoproteins)IBA 08/2010
1	pegvisomant FDA LinkGeneric 08/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2010
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2010
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2010
1	Transcription Factors (Transcription Factor)IBA 01/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2007
1	Metformin (Glucophage)FDA LinkGeneric 11/2007
1	AndrogensIBA 03/2007

Therapy/Procedure

8	Therapeutics 01/2022 - 12/2011
1	Combined Modality Therapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2020
1	Thyroidectomy 04/2011
1	Adrenalectomy 06/2010
1	Ovariectomy (Oophorectomy) 03/2007